Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE COX-2 and MMP-13 can be used as reference indexes to guide the treatment of gastric cancer and predict the disease prognosis. 30941969

2019

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Finally, we demonstrated that combinatorial inhibition of COX-2 and DNMT using Celecoxib and Decitabine synergistically inhibited GC growth <i>in vitro</i> and <i>in vivo</i>. 31534549

2019

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer. 31473273

2019

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE COX-2 and MMP-13 can be used as reference indexes to guide the treatment of gastric cancer and predict the disease prognosis. 30003735

2019

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 PosttranslationalModification BEFREE This work aimed to study COX-2 methylation and expression in N-methyl-N-Nitrosurea (MNU)-induced intestinal GC in six Sapajus apella animals. 29767663

2019

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Combined administration of γ-secretase and COX-2 inhibitor produced a marked inhibition of growth in AGS cells, which suggests that patients with poorly differentiated GC may benefit from the blockage of NICD, which potentially serves a role in GC differentiation. 29616098

2018

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE In 180 cases of GC, the clinicopathologic features were correlated with the results obtained after paired immunohistochemical stains (tumor/normal mucosa) with 15 antibodies: E-cadherin, HER-2, VEGF, CD31, CD105, COX-2, maspin, bax, bcl-2, p53, Ki67, MLH-1, MSH-2, Mena protein, and vimentin. 26067133

2017

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Compound Wumei Powder Inhibits the Invasion and Metastasis of Gastric Cancer via Cox-2/PGE2-PI3K/AKT/GSK3<i>β</i>/<i>β</i>-Catenin Signaling Pathway. 29358963

2017

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- κB Signaling Pathways. 29151957

2017

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE Moreover, the overexpression of transcription factor C/EBPβ in gastric cancer interacted with NFκB and further regulates COX-2 expression. 26514342

2016

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. 27079437

2016

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 GeneticVariation BEFREE In this study, we examined two single nucleotide polymorphism (SNP) sites of COX-2 gene in gastric cancer patients and explored the effect of the SNPs on the morbidity of gastric cancer. 27352184

2015

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 PosttranslationalModification BEFREE No significant association was found between COX-2 methylation and risk of GC (OR, 1.15; 95% CI: 0.70-1.88). 26674784

2015

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE COX-2 is expressed in DCAMKL1-expressing quiescent tuft cells in gastric carcinoma. 25228975

2014

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE We confirm loss of ANXA1 and overexpression of COX-2 in clinical gastric cancer, suggesting that the anti-proliferative function of ANXA1 against COX-2 production might be lost. 25038797

2014

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE Together, these findings provide new evidence for a positive feedback loop between STAT3 signaling and COX-2 in H. pylori pathogenesis and may lead to new approaches for early detection and effective therapy of gastric cancer 24127267

2014

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 GeneticVariation BEFREE Among the Chinese Hui ethnic group COX-2 -765 C allele carriers were at increased risk for gastric cancer (OR=1.977, 95%CI=1.104-3.541). 24935598

2014

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE The role of anti-LeY antibody in the downregulation of MAPKs/COX-2 pathway in gastric cancer. 24533777

2014

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer. 23670240

2013

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE Notch2-induced COX-2 expression enhancing gastric cancer progression. 21976141

2012

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE COX-2 is overexpressed in various cancers, including gastric cancer. 22385256

2012

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 Biomarker BEFREE COX-2 might mediate tumor angiogenesis and growth, and could be considered as a target for gastric cancer therapy. 21266034

2011

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 GeneticVariation BEFREE COX-2 -899C carrier (GC + CC) increased risk of gastric carcinoma with an odds ratio 1.950 (95% CI: 1.067-3.586, P=0.029). 20364406

2011

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 GeneticVariation BEFREE Our results suggested that the COX-2 promoter polymorphisms were associated with increased risk of GC, especially interacting with H. pylori infection. 21538574

2011

Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.100 AlteredExpression BEFREE HPSE and COX-2 are preferentially up-regulated in Barrett's oesophagus and intestinal-type GC. 20653782

2010